Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

2327. Schmidt L, Junker K, Weirich G, Glenn
G, Choyke P, Lubensky I, Zhuang Z, Jeffers
M, Vande Woude G, Neumann H, Walther
M, Linehan WM, Zbar B (1998). Two North
American families with hereditary papillary
renal carcinoma and identical novel mutations
in the MET proto-oncogene. Cancer
Res 58: 1719-1722.
2328. Schmidt LS, Warren MB, Nickerson
ML, Weirich G, Matrosova V, Toro JR,
Turner ML, Duray P, Merino M, Hewitt S,
Pavlovich CP, Glenn G, Greenberg CR,
Linehan WM, Zbar B (2001). Birt-Hogg-Dube
syndrome, a genodermatosis associated
with spontaneous pneumothorax and kidney
neoplasia, maps to chromosome 17p11.2.
Am J Hum Genet 69: 876-882.
2329. Schmitz-Drager BJ, Goebell PJ, Ebert
T, Fradet Y (2000). p53 immunohistochemistry
as a prognostic marker in bladder cancer.
Playground for urology scientists? Eur
Urol 38: 691-699.
2330. Schmitz-Drager BJ, Kushima M,
Goebell P, Jax TW, Gerharz CD, Bultel H,
Schulz WA, Ebert T, Ackermann R (1997). p53
and MDM2 in the development and progression
of bladder cancer. Eur Urol 32: 487-493.
2331. Schmitz-Drager BJ, van Roeyen CR,
Grimm MO, Gerharz CD, Decken K, Schulz
WA, Bultel H, Makri D, Ebert T, Ackermann R
(1994). P53 accumulation in precursor
lesions and early stages of bladder cancer.
World J Urol 12: 79-83.
2332. Schned AR, Ledbetter JS, Selikowitz
SM (1986). Primary leiomyosarcoma of the
seminal vesicle. Cancer 57: 2202-2206.
2333. Schneider A, Brand T, Zweigerdt R,
Arnold H (2000). Targeted disruption of the
Nkx3.1 gene in mice results in morphogenetic
defects of minor salivary glands: parallels
to glandular duct morphogenesis in
prostate. Mech Dev 95: 163-174.
2334. Schneider DT, Schuster AE, Fritsch
MK, Hu J, Olson T, Lauer S, Gobel U,
Perlman EJ (2001). Multipoint imprinting
analysis indicates a common precursor cell
for gonadal and nongonadal pediatric germ
cell tumors. Cancer Res 61: 7268-7276.
2335. Schoenberg M, Cairns P, Brooks JD,
Marshall FF, Epstein JI, Isaacs WB,
Sidransky D (1995). Frequent loss of chromosome
arms 8p and 13q in collecting duct carcinoma
(CDC) of the kidney. Genes
Chromosomes Cancer 12: 76-80.
2336. Schoenberg M, Kiemeney L, Walsh PC,
Griffin CA, Sidransky D (1996). Germline
translocation t(5;20)(p15;q11) and familial
transitional cell carcinoma. J Urol 155: 1035-
1036.
2337. Schoenberg MP, Hakimi JM, Wang S,
Bova GS, Epstein JI, Fischbeck KH, Isaacs
WB, Walsh PC, Barrack ER (1994).
Microsatellite mutation (CAG24—>18) in the
androgen receptor gene in human prostate
cancer. Biochem Biophys Res Commun 198:
74-80.
2338. Schofield DE, Yunis EJ, Fletcher JA
(1993). Chromosome aberrations in
mesoblastic nephroma. Am J Pathol 143:
714-724.
2339. Schraml P, Kononen J, Bubendorf L,
Moch H, Bissig H, Nocito A, Mihatsch MJ,
Kallioniemi OP, Sauter G (1999). Tissue
microarrays for gene amplification surveys
in many different tumor types. Clin Cancer
Res 5: 1966-1975.
2340. Schraml P, Muller D, Bednar R, Gasser
T, Sauter G, Mihatsch MJ, Moch H (2000).
Allelic loss at the D9S171 locus on chromosome
9p13 is associated with progression of
papillary renal cell carcinoma. J Pathol 190:
457-461.
2341. Schraml P, Struckmann K, Bednar R,
Fu W, Gasser T, Wilber K, Kononen J,
Sauter G, Mihatsch MJ, Moch H (2001).
CDKNA2A mutation analysis, protein
expression, and deletion mapping of chromosome
9p in conventional clear-cell
renal carcinomas: evidence for a second
tumor suppressor gene proximal to
CDKN2A. Am J Pathol 158: 593-601.
2342. Schraml P, Struckmann K, Hatz F,
Sonnet S, Kully C, Gasser T, Sauter G,
Mihatsch MJ, Moch H (2002). VHL mutations
and their correlation with tumour cell
proliferation, microvessel density, and
patient prognosis in clear cell renal cell
carcinoma. J Pathol 196: 186-193.
2343. Schubert GE, Pavkovic MB, Bethke-
Bedurftig BA (1982). Tubular urachal remnants
in adult bladders. J Urol 127: 40-42.
2344. Schullerus D, Herbers J, Chudek J,
Kanamaru H, Kovacs G (1997). Loss of heterozygosity
at chromosomes 8p, 9p, and
14q is associated with stage and grade of
non-papillary renal cell carcinomas. J
Pathol 183: 151-155.
2345. Schullerus D, von Knobloch R,
Chudek J, Herbers J, Kovacs G (1999).
Microsatellite analysis reveals deletion of
a large region at chromosome 8p in conventional
renal cell carcinoma. Int J
Cancer 80: 22-24.
2346. Schutte B (1988). Early testicular cancer
in severe oligozoospermia. In: Carl
Schirren Symposium: Advances in
Andrology, AF Holstein, F Leidenberger, HK
Holzer, G Bettendorf, eds. Diesbach
Verlag: Berlin, pp. 188-190.
2347. Schwerk WB, Schwerk WN, Rodeck
G (1987). Testicular tumors: prospective
analysis of real-time US patterns and
abdominal staging. Radiology 164: 369-374.
2348. Scott RJr, Mutchnik DL, Laskowski
TZ, Schmalhorst WR (1969). Carcinoma of
the prostate in elderly men: incidence,
growth characteristics and clinical significance.
J Urol 101: 602-607.
2349. Scully RE (1950). Spermatocytic
seminoma of the testis. A report of 3 cases
and review of the literature. Cancer 14:
788-794.
2350. Scully RE (1970). Gonadoblastoma. A
review of 74 cases. Cancer 25: 1340-1356.
2351. Seery WH (1968). Granular cell
myoblastoma of the bladder: report of a
case. J Urol 100: 735-737.
2352. Segawa N, Mori I, Utsunomiya H,
Nakamura M, Nakamura Y, Shan L, Kakudo
K, Katsuoka Y (2001). Prognostic significance
of neuroendocrine differentiation,
proliferation activity and androgen receptor
expression in prostate cancer. Pathol
Int 51: 452-459.
2353. Segelov E, Cox KM, Raghavan D,
McNeil E, Lancaster L, Rogers J (1993). The
impact of histological review on clinical
management of testicular cancer. Br J
Urol 71: 736-738.
2354. Sehdev AE, Pan CC, Epstein JI (2001).
Comparative analysis of sampling methods
for grossing radical prostatectomy specimens
performed for nonpalpable (stage
T1c) prostatic adenocarcinoma. Hum
Pathol 32: 494-499.
2355. Sehested M, Jacobsen GK (1987).
Ultrastructure of syncytiotrophoblast-like
cells in seminomas of the testis. Int J
Androl 10: 121-126.
2356. Seibel JL, Prasad S, Weiss RE,
Bancila E, Epstein JI (2002). Villous adenoma
of the urinary tract: a lesion frequently
associated with malignancy. Hum Pathol
33: 236-241.
2357. Selli C, Amorosi A, Vona G, Sestini R,
Travaglini F, Bartoletti R, Orlando C (1997).
Retrospective evaluation of c-erbB-2
oncogene amplification using competitive
PCR in collecting duct carcinoma of the
kidney. J Urol 158: 245-247.
2358. Selli C, Montironi R, Bono A, Pagano
F, Zattoni F, Manganelli A, Selvaggi FP,
Comeri G, Fiaccavento G, Guazzieri S,
Lembo A, Cosciani-Cunico S, Potenzoni D,
Muto G, Mazzucchelli R, Santinelli A
(2002). Effects of complete androgen
blockade for 12 and 24 weeks on the
pathological stage and resection margin
status of prostate cancer. J Clin Pathol 55:
508-513.
2359. Semenza JC, Ziogas A, Largent J,
Peel D, Anton-Culver H (2001). Gene-environment
interactions in renal cell carcinoma.
Am J Epidemiol 153: 851-859.
2360. Senel MF, van Buren CT, Riggs S,
Clark J3rd, Etheridge WB, Kahan BD
(1996). Post-transplantation lymphoproliferative
disorder in the renal transplant
ureter. J Urol 155: 2025.
2361. Senoh H, Ichikawa Y, Okuyama A,
Takaha M, Sonoda T (1986). Cavernous
hemangioma of scrotum and penile shaft.
Urol Int 41: 309-311.
2362. Serra AD, Hricak H, Coakley FV, Kim
B, Dudley A, Morey A, Tschumper B,
Carroll PR (1998). Inconclusive clinical and
ultrasound evaluation of the scrotum:
impact of magnetic resonance imaging on
patient management and cost. Urology 51:
1018-1021.
2363. Serrano-Olmo J, Tang CK, Seidmon
EJ, Ellison NE, Elfenbein IB, Ming PM
(1993). Neuroblastoma as a prominent
component of a mixed germ cell tumor of
testis. Cancer 72: 3271-3276.
2364. Serth J, Kuczyk MA, Bokemeyer C,
Hervatin C, Nafe R, Tan HK, Jonas U
(1995). p53 immunohistochemistry as an
independent prognostic factor for superficial
transitional cell carcinoma of the
bladder. Br J Cancer 71: 201-205.
2365. Sesterhenn I, Davis CJJr, Mostofi FK
(1987). Undifferentiated malignant epithelial
tumors involving serosal surfaces of
scrotum and abdomen in young males. J
Urol 137: 214.
2366. Sesterhenn IA, Mostofi FK, Davis CJ
(1986). Testicular tumours in infants and
children. In: Advances in the Biosciences
Germ Cell Tumours II, WG Jones, ed.
Pergamon Press: Oxford, pp. 173-184.
2367. Sesterhenn IA, Weiss RB, Mostofi
FK, Stablein DM, Rowland RG, Falkson G,
Rivkind SE, Vogelzang NJ (1992).
Prognosis and other clinical correlates of
pathologic review in stage I and II testicular
carcinoma: a report from the Testicular
Cancer Intergroup Study. J Clin Oncol 10:
69-78.
2368. Sevenet N, Sheridan E, Amram D,
Schneider P, Handgretinger R, Delattre O
(1999). Constitutional mutations of the
hSNF5/INI1 gene predispose to a variety
of cancers. Am J Hum Genet 65: 1342-
1348.
2369. Sexton WJ, Lance RE, Reyes AO,
Pisters PW, Tu SM, Pisters LL (2001). Adult
prostate sarcoma: the M.D. Anderson
Cancer Center Experience. J Urol 166: 521-
525.
2370. Seymour JF, Solomon B, Wolf MM,
Janusczewicz EH, Wirth A, Prince HM
(2001). Primary large-cell non-Hodgkin’s
lymphoma of the testis: a retrospective
analysis of patterns of failure and prognostic
factors. Clin Lymphoma 2: 109-115.
2371. Sgambato A, Migaldi M, Faraglia B,
de Aloysio G, Ferrari P, Ardito R, de
Gaetani C, Capelli G, Cittadini A, Trentini
GP (2002). Cyclin D1 expression in papillary
superficial bladder cancer: its association
with other cell cycle-associated proteins,
cell proliferation and clinical outcome. Int
J Cancer 97: 671-678.
2372. Sgrignoli AR, Walsh PC, Steinberg
GD, Steiner MS, Epstein JI (1994).
Prognostic factors in men with stage D1
prostate cancer: identification of patients
less likely to have prolonged survival after
radical prostatectomy. J Urol 152: 1077-
1081.
2373. Shaaban AA, Javadpour N, Tribukait
B, Ghoneim MA (1992). Prognostic significance
of flow-DNA analysis and cell surface
isoantigens in carcinoma of bilharzial
bladder. Urology 39: 207-210.
2374. Shah RB, Zhou M, LeBlanc M, Snyder
M, Rubin MA (2002). Comparison of the
basal cell-specific markers, 34betaE12 and
p63, in the diagnosis of prostate cancer.
Am J Surg Pathol 26: 1161-1168.
2375. Shamberger RC, Smith EI, Joshi VV,
Rao PV, Hayes FA, Bowman LC,
Castleberry RP (1998). The risk of nephrectomy
during local control in abdominal
neuroblastoma. J Pediatr Surg 33: 161-164.
2376. Shannon RL, Ro JY, Grignon DJ,
Ordonez NG, Johnson DE, Mackay B, Tetu
B, Ayala AG (1992). Sarcomatoid carcinoma
of the prostate. A clinicopathologic
study of 12 patients. Cancer 69: 2676-2682.
2377. Shapeero LG, Vordermark JS (1993).
Epidermoid cysts of testes and role of
sonography. Urology 41: 75-79.
2378. Sharpe RM, Skakkebaek NE (1993).
Are oestrogens involved in falling sperm
counts and disorders of the male reproductive
tract? Lancet 341: 1392-1395.
2379. Shaw JL, Gislason GJ, Imbriglia JE
(1958). Transition of cystitis glandularis to
primary adenocarcinoma of the bladder. J
Urol 79: 815-822.
2380. Shaw ME, Elder PA, Abbas A,
Knowles MA (1999). Partial allelotype of
schistosomiasis-associated bladder cancer.
Int J Cancer 80: 656-661.
2381. Shearer P, Parham DM, Fontanesi J,
Kumar M, Lobe TE, Fairclough D, Douglass
EC, Wilimas J (1993). Bilateral Wilms
tumor. Review of outcome, associated
abnormalities, and late effects in 36 pediatric
patients treated at a single institution.
Cancer 72: 1422-1426.
2382. Sheil O, Redman CW, Pugh C (1991).
Renal failure in pregnancy due to primary
renal lymphoma. Case report. Br J Obstet
Gynaecol 98: 216-217.
2383. Sheldon CA, Clayman RV, Gonzalez R,
Williams RD, Fraley EE (1984). Malignant
urachal lesions. J Urol 131: 1-8.
2384. Shen T, Zhuang Z, Gersell DJ,
Tavassoli FA (2000). Allelic deletion of VHL
gene detected in papillary tumors of the
broad ligament, epididymis, and retroperitoneum
in von Hippel-Lindau disease
patients. Int J Surg Pathol 8: 207-212.
2385. Shende A, Wind ES, Lanzkowsky P
(1979). Intrarenal neuroblastoma mimicking
Wilms’ tumor. N Y State J Med 79: 93.
2386. Shepherd D, Keetch DW, Humphrey
PA, Smith DS, Stahl D (1996). Repeat biopsy
strategy in men with isolated prostatic
intraepithelial neoplasia on prostate needle
biopsy. J Urol 156: 460-462.
2387. Sherif A, de la Torre M, Malmstrom
PU, Thorn M (2001). Lymphatic mapping
and detection of sentinel nodes in patients
with bladder cancer. J Urol 166: 812-815.
342 References